Reveal Technology Raises $30 Million Series B Led by Ballistic Ventures
Cybersecurity veteran Kevin Mandia joins board as defense tech company expands battlefield-ready solutions BOZEMAN, Mont., July 29, 2025 /PRNewswire/ — Reveal... Read more.
Fractal Launches Cogentiq, an Agentic AI Platform to drive Enterprise Performance
NEW YORK, July 29, 2025 /PRNewswire/ — Fractal (www.fractal.ai), a global provider of artificial intelligence solutions to Fortune® 500 enterprises, today... Read more.
Tandym Group Announces General Availability of Agentic AI Products on Tandym Catalyst™ Platform
New Products for Sourcing and Evaluating Candidates, Reducing Hiring Tasks From Days to Minutes NEW YORK, July 29, 2025 /PRNewswire/ — Tandym Group, a leading... Read more.
LG Innotek Teams Up with U.S. LiDAR Company Aeva in Preparation to Preempt the Market
Selected as Aeva’s supplier for an ultra-slim, ultra-long-range 4D LiDAR Joint development of LiDAR for autonomous driving car∙robots∙industrial automation,... Read more.
Ceva Retains Top Spot in Wireless Connectivity IP in Latest IPnest Report
68% market share in 2024; Cements Ceva’s dominance in Bluetooth, Wi-Fi, UWB, 802.15.4 and cellular IoT IP and integral role of connectivity for smart edge... Read more.
Johnson Controls Reports Strong Q3 Results; Raises FY25 Guidance
Q3 sales increased 3% and organic sales increased 6%* Q3 GAAP EPS of $0.94; Q3 Adjusted EPS* of $1.05 Q3 orders increased 2% organically year-over-year Systems and... Read more.
ArisGlobal Achieves Strong Global Growth and Continued Innovation in First Half 2025
Expanding Impact of LifeSphere® NavaX™ Across the Industry, 27 Go-Lives, and New Global Pharma Adoptions BOSTON, July 29, 2025 /PRNewswire/ — ArisGlobal,... Read more.
Hyperscale Data Subsidiary Alliance Cloud Services Enters Agreement with Local Utility Provider to Advance Natural Gas Infrastructure for Michigan Data Center
Natural Gas Pipeline Infrastructure to Enable Approximately 40 MW of Incremental Power to Michigan Data Center LAS VEGAS, July 29, 2025 /PRNewswire/ — Hyperscale... Read more.
Lilly’s Jaypirca (pirtobrutinib), the first and only approved non-covalent (reversible) BTK inhibitor, met its primary endpoint in a head-to-head Phase 3 trial versus Imbruvica (ibrutinib) in CLL/SLL
Pirtobrutinib met the primary endpoint of response rate non-inferiority, favoring pirtobrutinib with a nominal P-value for superiority < 0.05 Progression-free... Read more.
Creyos Featured in Alzheimer’s Research at AAIC 2025
Findings from Western University, QIMR Berghofer, and Rotman Research Institute underscore the power of Creyos in detecting early risk, validating digital testing,... Read more.